종목별 Investment Strategy Summary — 2026-06-10
Here’s a quick summary of the latest analyst reports on our holdings. Following the strong market rebound on June 9, gene therapy stocks and the management shake-up at Kakao Games have been the main topics grabbing everyone's attention.
종목별 Investment Strategy Summary — 2026-06-10
Large-Cap and Key Holding Reports
Kakao (035720) Kakao hit a 52-week low, dropping over 5%. Despite hopes for AI service integration, analysts say the lack of clear results—like a boost in KakaoTalk usage time—is weighing on investor sentiment.
Hanon Systems (018880) Hanon Systems saw slight profit improvements due to a better cost structure, but reports suggest that high interest expenses and overhang risks (potential selling pressure) related to the second-largest shareholder's stake are still holding the stock back. The target price remains at 4,200 won.
Bio and Tech Growth Stock Analysis
Gene Therapy Sector Strength With the domestic stock market staging a strong rebound for the first time in four days on June 9—largely thanks to easing geopolitical risks in the Middle East—gene therapy and cell/gene therapy-related bio stocks rallied across the board. Genexine, SillaJen, AbClon, and ToolGen all climbed together, reflecting a recovery in bio sector sentiment.
L&C Bio (290650) L&C Bio showed an upward trend, bolstered by supply-demand momentum and valuation re-ratings. It rose 0.58%, closing at 86,700 won compared to the previous trading day's 86,200 won.
Seegene (096530) Seegene solidified its No. 1 spot in the June brand reputation rankings for life science service companies, posting a sharp 31% jump.
IT/Game Sector Strategy
Kakao Games (063080) Kakao Games is welcoming an investment vehicle from LINE Yahoo as its new largest shareholder. While this brings a major capital infusion and helps secure management stability, the key challenge moving forward will be breaking through stagnant earnings and strengthening competitiveness in new businesses.
Overall Market Direction
On June 9, the KOSPI closed at 8,096.93, up 612.52 points (+8.18%), while the KOSDAQ rose 56.42 points (+6.19%) to close at 967.81. The recovery was led by the strong rebound in the bio sector and easing geopolitical risks in the Middle East.
Currently, Kakao remains weak due to a lack of verified earnings from its delayed AI monetization, and Kakao Games is in a period of stabilization following its management reshuffle. Conversely, gene therapy-related bio stocks are showing strong gains, riding the wave of improving market sentiment.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
